Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1Phase 1/2 1Phase 1 1

Status

Completed 3Recruiting 1

Sponsor Class

INDUSTRY 4

Study Type

Interventional 4

Sponsor

Cancer Type

Thoracic 4Gynecologic 3Lymphoid 2Sarcoma 1Other solid neoplasm 1Gastrointestinal 1Breast 1

Conditions

Small Cell Lung Carcinoma 4

Interventions

Carboplatin 1152Cisplatin 876Pemetrexed 834pembrolizumab 608Paclitaxel 598Docetaxel 535Gemcitabine 424Radiotherapy 377Erlotinib Hydrochloride 367Nivolumab 322Bevacizumab 322Etoposide 295durvalumab 254Drug Therapy 233osimertinib 218atezolizumab 208Radiosurgery 190Gefitinib 177Vinorelbine 145130-nm albumin-bound paclitaxel 124Magnetic Resonance Spectroscopy 121Ipilimumab 118Cetuximab 113anlotinib 104tislelizumab 103Topotecan 101Cyclophosphamide 101Taxes 99Irinotecan 95Albumin-Bound Paclitaxel 92

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Interventional × chiauranib × Thoracic × Clear all
NCT04830813 2024-12-09

Phase 3 Clinical Study of Chiauranib Capsule in Patients With Small-cell Lung Cancer

Chipscreen Biosciences, Ltd.

Phase 3 Completed
184 enrolled
Thoracic

Small Cell Lung Carcinoma

NCT05271292 2024-07-16

SCLC

Chipscreen Biosciences, Ltd.

Phase 1/2 Recruiting
36 enrolled
Thoracic

Small Cell Lung Carcinoma

NCT05371899 2024-07-15

Mass Balance Study of [14C]Chiauranib

Chipscreen Biosciences, Ltd.

Phase NA Completed
6 enrolled
Thoracic

Small Cell Lung Carcinoma

NCT03216343 2023-08-30

Phase Ib/II Study of Chiauranib in Patients With Small Cell Lung Cancer

Chipscreen Biosciences, Ltd.

Phase 1 Completed
48 enrolled
Thoracic

Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡